Lymphoma triage from H&E using AI for improved clinical management

Author:

Tsakiroglou Anna MariaORCID,Bacon Chris M,Shingleton Daniel,Slavin Gabrielle,Vogiatzis Prokopios,Byers Richard,Carey Christopher,Fergie Martin

Abstract

AimsIn routine diagnosis of lymphoma, initial non-specialist triage is carried out when the sample is biopsied to determine if referral to specialised haematopathology services is needed. This places a heavy burden on pathology services, causes delays and often results in over-referral of benign cases. We aimed to develop an automated triage system using artificial intelligence (AI) to enable more accurate and rapid referral of cases, thereby addressing these issues.MethodsA retrospective dataset of H&E-stained whole slide images (WSI) of lymph nodes was taken from Newcastle University Hospital (302 cases) and Manchester Royal Infirmary Hospital (339 cases) with approximately equal representation of the 3 most prevalent lymphoma subtypes: follicular lymphoma, diffuse large B-cell and classic Hodgkin’s lymphoma, as well as reactive controls. A subset (80%) of the data was used for training, a further validation subset (10%) for model selection and a final non-overlapping test subset (10%) for clinical evaluation.ResultsAI triage achieved multiclass accuracy of 0.828±0.041 and overall accuracy of 0.932±0.024 when discriminating between reactive and malignant cases. Its ability to detect lymphoma was equivalent to that of two haematopathologists (0.925, 0.950) and higher than a non-specialist pathologist (0.75) repeating the same task. To aid explainability, the AI tool also provides uncertainty estimation and attention heatmaps.ConclusionsAutomated triage using AI holds great promise in contributing to the accurate and timely diagnosis of lymphoma, ultimately benefiting patient care and outcomes.

Funder

Spotlight Pathology Ltd

Publisher

BMJ

Subject

General Medicine,Pathology and Forensic Medicine

Reference25 articles.

1. Cancer Research UK . Statistics by cancer type. 2023. Available: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type

2. Global patterns of non-Hodgkin lymphoma in 2020;Mafra;Int J Cancer,2022

3. Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040;Singh;Int J Cancer,2022

4. Leukemia & Lymphoma Society . Facts 2020-2021. n.d. Available: https://www.lls.org/lymphoma

5. Haematological cancers: improving outcomes [NICE Guideline no.47]. 2016. Available: https://www.nice.org.uk/guidance/NG47

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3